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Ceils of the mononuelear phagocytic system possess specific receptors for 3'G-glob- 
ulin (3,G)  l  (1) and for  the third component of the complement system, C3  (2). The 
characteristics of these receptors have been studied in vitro with rosette formation of 
coated  erythrocytes around macrophages  (3).  The in vitro adherence of antibody- 
coated erythrocytes to macrophages was inhibited by less than physiological amounts 
of free  3'G in the medium. This inhibition was overcome by adding complement, a 
fact which suggests that complement may be necessary in vivo to mediate the uptake 
of immune complexes.  However, recent in vivo studies showed  no differences  in the 
uptake of soluble immune complexes  by the fixed macrophages of the liver after in- 
fusion into either normal or complement-depleted rabbits (4). The in vitro adherence 
of  soluble immune complexes  to  macrophages has  not  been characterized.  Macro- 
phages may interact in a different fashion with soluble complexes than with antibodies 
on particulate antigens; this is because actual lattice formation does not exist with 
particulate antigens sensitized by subagglutinating  amounts of antibodies. 
Soluble immune complexes  and  aggregated  3,G-globulin have  been  thought  to 
possess  equivalent biological properties on a weight basis.  Complement fixation, fix- 
ation to skin, and the ability to induce an Arthus lesion were comparable when the 
same amounts of homologous 3'G were employed in soluble complexes  or aggregates 
(5). Complement fixation by soluble complexes (6) and adherence of soluble complexes 
to macrophages (7) were attributed primarily to a  summation of individual binding 
sites offered  by many antibodies in the lattice work.  The presence of the same bio- 
logical properties in heat-aggregated 3'G was concluded to  be due  to an analogous 
increase in the number and proximity of binding sites (8). 
The present studies were designed to characterize the in vitro adherence of 
soluble complexes to macrophages. The data supported the conclusion that sol- 
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uble immune complexes containing more than two molecules of antibody prefer- 
entially  adhered  to macrophages  in the  absence  of complement.  Furthermore, 
the inhibition of adherence by free ~,G was not significantly altered by the addi- 
tion of complement.  Soluble complexes and homologous aggregated ~/G of com- 
parable  size were compared with respect  to their relative abilities to  adhere  to 
macrophages  and  to  fix  complement.  The  data  suggested  that  the 
strength  of binding  of soluble  immune complexes to macrophages  and  the effi- 
ciency in fixing complement were not determined solely by a random summation 
of individual binding sites.  Possible mechanisms of these biological activities of 
soluble complexes are discussed. 
Materials and Methods 
Preparation of Immune Complexes.--New Zealand rabbits were hyperimmunized with hu- 
man serum albumin  (HSA, five times crystallized, Schwarz Bio Research Inc., Orangeburg, 
N.Y.) emulsified in complete Freund's adjuvant (CFA). Each rabbit was injected subcutane- 
ously with 1-2 mg of HSA weekly for 4 wk. Booster injections were given at monthly intervals 
during which time weekly bleedings were obtained. Specific antibodies were isolated from the 
antisera  by  immunoadsorbent  techniques previously described  (9).  Elution from adsorbent 
columns was performed with 2.5 ~t KI. All studies were subsequently carried out with proteins 
in sodium borate buffer (0.2 M sodium borate, 0.16 M NaC1, pH 8.0).  The purified antibodies 
were radiolabeled with 1~I by the monochloride method (10) to yield 1-2 moles of iodine per 
mole of 7G. Approximately 1 mCi of 1251 was used per 10 mg of protein; a  specific activity of 
30,000-60,000  cpm//zg was achieved. For some studies, HSA was similarly labeled with l~lI. 
Free isotope was removed by exhaustive dialysis against borate buffer. Reduction and alkyla- 
tion of antibodies were carried  out  respectively with 0.1  ~  2-mercaptoethanol  and  0.11 
iodoacetamide in borate buffer. Monomeric antigen and antibody preparations were obtained 
by  gel  filtration on  Sephadex  G-200  (Pharmacia  Fine  Chemicals,  Inc.,  Piscataway,  N.J.), 
either after iodination or after reduction and alkylation. The point of equivalence was deter- 
mined by quantitative precipitin curves. Soluble complexes were prepared at threefold antigen 
excess  (by weight) by adding antibodies to antigen while stirring. 
Preparation of Proteins  for Inhibition.--Rabbit,  human, or sheep TG-globulin (subsequently 
abbreviated  RGG,  HGG,  or  SGG, respectively; Schwarz Bio Research  Inc.)  were further 
purified by gel filtration on Sephadex G-200.  The excluded and included peaks were concen- 
trated and utilized for further studies as minimally aggregated or monomeric proteins, respec- 
tively. Double diffusion in agar with antibodies to whole serum, or to TG, showed no evidence 
of the presence of proteins other than "),G-globulin in the aggregated or monomeric RGG or 
HGG preparations.  Heavily aggregated RGG was obtained by heating  the G-200-excluded 
preparation at 71°C for 20 min (11). 
Macrophage Preparation.--For preliminary  studies,  rabbit  peritoneal  macrophages  were 
obtained by irrigating the peritoneum with Hanks'  solution  (without Ca++; containing 0.05 
mg heparin/ml)  3-4 days after injection of 30  ml of heavy mineral oil (Muri-Lube Heavy, 
Invenex  Pharmaceuticals,  San  Francisco,  Calif.).  For  all  studies  not  otherwise  specified, 
stimulated rabbit alveolar macrophages were utilized. These were obtained by modifications 
of the methods described by Myrvik et al. (12). 2-kg New Zealand rabbits were injected intra- 
venously with 0.1  ml of CFA (Difco Laboratories, Detroit, Mich.), with repeated injections 
given at 2-3-wk intervals. Most animals were utilized within 1-3 wk of injection of the last 
adjuvant dose. The animals were sacrificed by air embolism. The lungs were carefully removed 
and then irrigated with warm Hanks' solution, using 10 washings of 30 ml each. The cells were 
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cells present were lysed by a  brief exposure to hypotonic saline (0.2% NaCI for 20 sec).  The 
washed ceils were finally suspended in Medium 199 (Microbiological Associates, Inc., Bethesda, 
Md.)  (containing 0.05 mg/ml heparin, 100 units/ml penicillin, and 100 #g/ml streptomycin) 
at a  concentration of 4  X  107 cells/ml.  Viability was assessed by trypan blue dye exclusion 
and was greater  than 97% in every experiment. The cell preparations consisted of 85-90% 
macrophages and  10-15%  other ceils including lymphocytes,  neutrophils, and eosinophiles. 
The cells were utilized for experiments within 4 hr of removal from the animal. All glassware 
was siliconized. 
Immune Complex Adherence and Inhibition Studies.--These procedures were modified from 
the methods described by Phillips-Quagliata et al.  (7). All solutions were made 1 g/100 ml in 
rabbit albumin (Cohn fraction V, Schwarz Bio Research Inc.; or crystallized rabbit albumin, 
Pentex  Biochemical,  Kankakee,  Ill.)  to  prevent  nonspecific adsorption  of  proteins  to  the 
siliconized test tubes (12 X  75 ram) or to the cells.  The 1 g/100 ml rabbit albumin solutions 
contained less than .50 #g/ml of rabbit "?G-globulin, as measured by radial immunodiffusion 
using specific  sheep antibodies to rabbit "/-chains (13).  2  X  107 cells  (in 0.5 ml of Medium 
199) were placed into each test tube and a  portion of the inhibiting protein in borate buffer 
was added. The volume was adjusted to 1 ml with borate buffer containing 1 g/100 ml rabbit 
albumin.  The  suspensions were  incubated at  room  temperature for  10  rain with frequent 
mixing. The cells were preincubated with the inhibiting protein before addition of the immune 
complexes in order to simulate in vivo conditions, in which the macrophages are presumably 
exposed to 3'G-globulins. A sample of the radiolabeled immune complexes was finally added 
(25/A containing 2 #g of antibody protein). Thereafter, the cells were incubated at 37°C  for 
30 min with frequent mixing. Under these conditions the cells usually remained in suspension 
and rarely clumped.  Preliminary experiments indicated that neither the order of mixing (i.e. 
preincubating the inhibiting protein with the labeled complexes,  then adding the cells), nor 
the length of incubation (up to 1 hr) altered the observed results. The tubes were then centri- 
fuged for 5 rain at 1000 g and 4°C, and the supernatant was decanted. The cell buttons were 
washed three times with  1 ml of Hanks'  solution. Preliminary studies showed that further 
washings contained insignificant amounts of radioactivity. 
The cells,  supernatants, and a sample of the washes were counted in a Packard automatic 
well-type gamma counter  (Packard Instrument Co.,  Downers Grove, Ill.).  The per cent of 
the radioactivity adherent to the cells was calculated.  Control tubes with a  packed volume 
of sheep red blood cells equal to the packed macrophage volume were included in every experi- 
ment. Even though the amount of complexes adsorbed to red cells was always only a fraction 
of 1%, this value was subtracted from the values obtained for the macrophages. The amount 
adherent in the presence of inhibiting protein was compared with the amount of complexes 
adherent to macrophages in daily control tubes containing no inhibiting protein. Assuming the 
latter  to be  100% adherence, the per cent inhibition of adherence of complexes with each 
amount of inhibiting protein was calculated. Each experiment was run in duplicate and often 
repeated two or more times as indicated in the results. 
Other Methods.--Distribution of soluble immune complexes or of aggregated proteins was 
determined by sucrose density gradient  (SDG)  ultracentrifugation, as previously described 
(9). 10  30% sucrose gradients were centrifuged at 37,000 rpm and 4°C for 16 hr. Anticomple- 
mentary cobra venom factor  (CoF)  was purified and assayed by described techniques (14). 
Complement fixation by soluble complexes and TG preparations was performed with serial 
dilutions of the proteins in Veronal buffer and 1.5 CHs0 units of guinea pig complement. The 
complexes and complement were incubated at 4°C for 18 hr. The amount of remaining com- 
plement was  determined by fixation by sensitized sheep red  blood cells  (15,  16).  Trypsin, 
chymotrypsin  (Worthington Biochemical Corp.,  Freehold,  N.J.),  or  pronase  (Calbioehem, 
Los Angeles, Calif.) were suspended in Hanks' solution (with Ca  ++  )  before use.  Protein con- 
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14.4 for rabbit anti-HSA, 6.6 for HSA, and 13.7 for HGG or SGG. Protein concentrations in 
SDG fractions of unlabeled proteins were determined by the Folin method (17). In calcula- 
tions of the molar ratio of antigen and antibody in immune complexes, the following  molecular 
weights were used: 145,000 for RGG and 67,000 for HSA. The fresh rabbit serum was obtained 
and pooled from the same animals that provided the stimulated alveolar macrophages. This 
pool possessed a CHs0 titer of 32 units. 
RESULTS 
Adherence  of HSA-Anti-HSA  Complexes.--Initial  experiments  showed that 
the  >  llS complexes selectively adhered to the macrophages in these in vitro 
studies. The 11S or smaller complexes containing two or one molecules of anti- 
body failed to adhere in the presence of larger complexes. Complexes were pre- 
pared at threefold antigen excess to obtain sufficient > llS complexes in dilute 
solutions. In such preparations 20-25% of antibodies were in the  > llS com- 
plexes (see Fig. 1). At these low concentrations of antibodies (2 #g of antibody 
protein in  1 ml),  the percentage of  > llS  complexes,  as determined by  SDG 
ultracentrifugation, was lower than in our previous studies performed at con- 
centrations 1000 times greater (4, 9). Experiments with radiolabeled monomeric 
HSA or anti-HSA indicated that less than 1% of free antigen or free antibodies 
adhered to the macrophages under the described experimental conditions. Studies 
performed with complexes in which both the antigen and antibodies were labeled 
with 1~1I and ~2~I, respectively, showed that the molar ratio of the protein ad- 
herent to the cells was identical to the molar ratio of the complexes greater than 
llS in  size,  as  determined by SDG.  These  >  llS  complexes contained  more 
than two molecules of antibody per complex3 
The  amount  of  complexes  adherent  to  stimulated  alveolar  macrophages 
ranged from 5 to 23 % of the total available radioactivity. The reasons for this 
variable binding of the > llS complexes remained unclear, but appeared to be 
related  to the time  elapsed  from  the  last  injection  of  CFA.  The  maximum 
adherence of complexes was greatest with macrophages obtained from animals 
injected 2-3 wk previously. The maximum binding was not related to the num- 
ber of times the rabbit had been injected, or to the total yield of cells,  which 
varied between 1.65 X  l0  s and 40.9 )<  l0  s cells per rabbit. 
Comparison  of Adherence  of  Complexes  to  Peritoneal  and  Alveolar  Macro- 
phages.--Alveolar  and peritoneal macrophages were not significantly different 
in their interaction with soluble immune complexes. Stimulated alveolar or peri- 
toneal macrophages were preincubated with serially increasing amounts of fresh 
rabbit serum; the last set of tubes contained 1 ml of serum. The concentration 
of normal RGG in this pool was 9540 t~g/ml,  as measured by radial immunodif- 
fusion. The per cent inhibition of adherence of complexes was calculated  and 
plotted  against the micrograms of  ~'G present  (Fig.  2).  With the  addition of 
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increasing amounts of normal serum, considerable inhibition of binding occurred 
early (50~4, inhibition of uptake at 790 #g of 3'G in serum), and then inhibition 
gradually rose to a maximum of 95 % by undiluted fresh serum. The stimulated 
alveolar macrophages behaved similarly to the stimulated peritoneal cells,  both 
in maximum binding of complexes (15.5 %  for the peritoneal cells)  and in char- 
acteristics of inhibition by serum. The stimulated alveolar cells were used in the 
remainder of these studies. 
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Fro.  1.  Sucrose  density  gradient  ultracentrifugation  patterns.  (A) HSA-anti-HSA com- 
plexes at threefold antigen excess; (B) minimally aggregated RGG. The top of each gradient 
is to the right (100%). In (A) the 10.8S peak represents primarily complexes containing two 
molecules of antibody and in  (B)  the 9S peak constitutes  dimers of RGG.  In each solution 
approximately  the same proportion of material is present between the dimer peaks and  19S, 
with little protein present larger than 19S in size. 
Role of Complement in the In Vitro Binding of Complexes.--These  experiments 
were designed to investigate whether complement could overcome the inhibition 
of adherence of soluble complexes in the presence of free 3'G. A  sample of the 
the fresh rabbit serum pool was decomplernented by heating at 56°C for 30 rain. 
Another  1 ml sample was depleted  of later  acting complement components by 
incubation  with  20 units/ml  of purified  CoF  at  37°C for 60 mill.  (This  is  ap- 
proximately  10 times  the  amount of CoF used  in the in vivo studies  [4].)  The WILLIAM  P.  AREND  AND  MART  MANNIK  519 
sera depleted  of complement by the two methods inhibited  adherence of com- 
plexes  in  an  identical  manner;  therefore the  results were plotted  together  for 
graphic analysis. 
The inhibition of adherence of complexes by decomplemented serum was the 
same as that produced by normal serum, when large amounts of "yG were pres- 
ent. However, at less than 500 #g of -yG/ml, the decomplemented sera inhibited 
IO0- 
u~ 
.~ 
~  40- 
~-~  20- 
,:b 
0 
0 
#,.o  #S 
tt I  S 
// 
[  ~' mocrophoges 
•  o--o Perdoneol J 
'  2o'oo  4obo  ~doo  '  so'oo  ,o,  boo 
fig  RGG  in  fresh  rabbit  serum 
FIG. 2.  Inhibition of adherence of immune complexes to stimulated peritoneal or alveolar 
cells  by  fresh  rabbit  serum. The  last  point  on  each  curve  represents inhibition  by  whole, 
undiluted  serum.  2  X  l0 T macrophages were  preincubated  with  the  inhibiting  protein  at 
room temperature for  10 rain,  then 2  #g of labeled complexes added and incubated  at 37°C 
for 30 rain.  The cells were washed three times. The amounts adherent  to  the macrophages 
were corrected by the amounts adherent to the same volume of packed red cells. Each point 
represents the average of duplicate determinations. 
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FiG.  3.  Inhibition of adherence of complexes to  macrophages by fresh rabbit serum, by 
decomplemented rabbit serum, or by monomeric RGG in borate buffer with 1 g/100 ml rab- 
bit albumin. The serum was decomplemented by heating at 56°C for 30 min, or by treatment 
with purified cobra venom factor.  Each point on every curve represents the average of four 
values. Note the change in scale of the abscissa from Fig. 2. 520  ADHERENCE  OF  SOLUBLE  COMPLEXES  TO  MACROPHAGES 
to a slightly higher degree (Fig. 3). The difference in inhibition between decom- 
plemented  and  normal  serum  was  not  affected by  the  length  of  incubation 
through 30 min, but decreased with longer incubation. Furthermore, the differ- 
ence was not altered by preincubating the serum with the complexes before the 
addition of cells.  These observations suggested that the assistance of comple- 
ment in  adherence of soluble complexes to macrophages was not significant in 
the presence of free "rG, when the concentration of the protein approached nor- 
mal serum levels. 
The inhibition curve of monomeric RGG in borate buffer (with 1 g/100 ml 
rabbit albumin) was not significantly different from that of 3'G present in whole 
serum (Fig. 3); 50% inhibition of adherence of complexes was given by 790 #g 
of RGG in fresh serunl and 710 ~zg of RGG in buffer. Therefore, other serum pro- 
teins did not affect the adherence of soluble complexes to macrophages under 
the conditions of our experiments. 
Inhibilion  of Adherence  of Complexes  by Aggregated or Monomeric  "yG from 
Various Species.--These studies were designed to determine the species specific- 
itv of the macrophage receptor for 3,G and the relative binding of aggregated 
and monomeric ~,G. Minimally aggregated and monomeric rabbit, human and 
sheep 3'G preparations were analyzed for size distributions by SDG ultracen- 
trifugation. The monomeric preparations contained less  than ~" eJ/,, of small  ag- 
gregates.  The minimally aggregated  preparations  consisted  of  approximately 
one-third each of monomers, dimers and larger aggregates with little material 
sedimenting faster than 19S (see Fig.  1). 
The inhibition of adherence of complexes to macrophages observed with mon- 
omeric or with aggregated ~,G showed marked species differences (Figs. 4 and 5). 
With either monomeric or aggregated "yG the inhibition observed was most ef- 
fective with rabbit 3'G, followed by human and then sheep 3'G. Also, with pro- 
teins within each species the degree of inhibition was greater with the aggregated 
than with the monomeric material. 
Effecl  of Reduclion  and Alkylation of ")G on Inhibition of Adherence  of Com- 
plexes.--The inhibition of binding of complexes by the reduced and alkylated 
rabbit 3'G solutions was less than that by the intact proteins (Fig. 6), although 
the  aggregated  "/G  still  inhibited  to  a  greater  degree  than  the  monomeric 
preparations. 13 times as much reduced and alkylated aggregated 7G than  in- 
tact aggregated 3"G was required to give 50% inhibition. By SDG ultracentrifu- 
gation  the  size  distributions  in  these  solutions  were  similar  to  those  of  the 
preparations with intact disulfide bonds (see Fig. 1). 
Inhibition of Adherence of Complexes by Preincubation  wiIh  Unlabeled Com- 
plexes Prepared with Intact or Reduced and Alkylated Antibodies.--The effect of 
reduction and alkylation of interchain disulfide bonds on the direct adherence 
of soluble complexes was first assessed by preparing complexes at threefold anti- 
gen  excess using  radiolabeled  reduced  and  alkylated  antibodies.  These com- 
plexes showed a marked decrease in adherence to macrophages. An experiment WILLIAM  P.  AREND  AND  MART MANNIK  521 
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FIo. 4.  Inhibition of adherence of complexes to macrophages by monomeric RGG, HGG, 
or SGG. Each experiment was carried out in duplicate. 
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FIG. 5.  Inhibition of adherence of complexes to macrophages by minimally aggregated 
RGG, HGG, or SGG, obtained by exclusion from G-200. The size distributions in each prep- 
aration were similar with approximately one-third each of 6.6S  monomers, 9S  dimers, and 
small aggregates between 10S and 19S. Each experiment was carried out in duplicate. 
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FIG. 6.  Inhibition of adherence of complexes by minimally aggregated, or monomeric, 
RGG, either with intact or reduced and alkylated disulfide bonds. Each point represents the 
average of duplicate values, red., reduced; alk., alkylated. 522  ADHERENCE  OF  SOLUBLE  COMPLEXES  TO  MACROPHAGES 
performed on the same macrophage preparation showed only 1.89% adherence 
of complexes with reduced and alkylated antibodies, as opposed to 17.4% bind- 
ing of complexes prepared with intact antibodies.  The distribution of complex 
sizes was similar in the two preparations,  as determined by SDG analysis. 
The strength of binding of complexes containing intact or reduced and alkyl- 
ated  antibodies was further  studied  by using these unlabeled  preparations  as 
inhibitors of the subsequent adherence of intact labeled complexes. The unla- 
beled soluble immune complexes prepared with intact or reduced and  alkylated 
antibodies had similar size distributions as the labeled complexes, i.e.  20-25 % 
of >  llS complexes. The completeness of reduction and alkylation of the anti- 
bodies was confirmed both by gel filtration under dissociating conditions and by 
complement  fixation.  The  reduced  and  alkylated  antibodies  separated  com- 
pletely into heavy and light chains when chromotographed on a Sephadex G-100 
TABLE I 
Complement  Fixation  and  Inhibition  of Adherence  of Complexes  to Macrophages  by  Unlabeled 
Immune Complexes, Aggregated RGG, or Monomeric  RGG 
Test protein  50"% inhibition  of  adherence*  50% complement fixation** 
Immune complexes with intact antibodies 
Immune complexes with reduced and alkylated 
antibodies 
Minimally aggregated RGG 
Heavily aggregated RGG 
Monomeric RGG 
~g  ~g 
5.0  0.92 
42  180 
95  250 
725  0.70 
710  415 
* 2 X  107 stimulated alveolar macrophages were preincubated with serially increasing 
amounts of test protein and the number of micrograms giving 50% inhibition of the subse- 
quent binding of 2 #g of labeled soluble immune complexes was determined. 
~C Micrograms of test protein fixing 50% of 1.5 CHs0 units of guinea pig complement. 
column equilibrated with 0.5 M propionic acid.  Also,  these complexes showed a 
200-fold difference in the efficiency  of complement fixation; 180 #g of reduced 
and  alkylated  antibodies in  complexes gave 50%  complement fixation as op- 
posed to 0.92 #g of intact antibodies in complexes (see Table I). Macrophages 
were preincubated with these unlabeled complexes, and the subsequent adher- 
ence of 2 #g of radiolabeled complexes with intact antibodies was determined. 
The complexes with intact  disulfide  bonds were  eight times more effective 
than complexes with reduced and alkylated antibodies as inhibitors  of subse- 
quent  complex binding.  50%  inhibition  of adherence was given by 5.0 #g of 
antibody in the former complexes as opposed to 42 #g of the latter (Fig. 7 and 
Table I). Furthermore, in the inhibition assay the complexes with reduced and 
alkylated antibodies were twice as efficient  as intact aggregated RGG, and 30 
times as efficient  as reduced and alkylated aggregated RGG. However, the rain- WILLIAM P.  AREND  AND  MART  MANNIK  523 
imally aggregated intact rabbit ~,G was much less efficient in fixing complement 
than soluble complexes made with intact antibodies; the former required 250/~g 
to give 50% complement fixation (see Table I). 
These experiments indicated that as inhibitory proteins in this in vitro sys- 
tem, homologous minimally aggregated ~G was less firmly bound to the macro- 
phages than were soluble immune complexes possessing antibodies with either 
intact or reduced and alkylated disulfide bonds. The weaker binding of the ag- 
gregated ~,G was further confirmed in an experiment using 2 #g of radiolabeled 
aggregated RGG as the test substance. 50% inhibition of binding of the aggre- 
gated RGG was achieved by preincubation of the cells with only 160 #g of unla- 
beled monomeric RGG, whereas five times that  amount was required  to give 
50% inhibition of adherence of soluble immune complexes. 
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FIG. 7.  Inhibition of adherence of labeled complexes by preincubation of the cells with 
unlabeled complexes prepared with intact  antibodies or with reduced (red.) and alkylated 
(alk.) antibodies. The unlabeled complexes consisted of the same size distributions as the 
labeled test complexes. Each point is the average of four values. Note the change in scale of 
the abscissa from the preceding figures. 
Inhibition of Adherence of Complexes by Aggregated Rabbit ~?G Possessing Com- 
plement-Fixing A bility Comparable with that of the Immune Complexes.--Because 
previous  investigators  concluded  that  soluble  complexes  and  aggregated  ~,G 
possessed similar biological properties on  a  weight basis  (5),  the inhibition  of 
adherence of complexes by heat-aggregated RGG was studied. This preparation 
required  only 0.70 ~g to give 50% complement fixation (Table I), an amount 
equivalent to that of the immune complexes with intact antibodies. The heat- 
aggregated RGG contained primarily aggregates sedimenting faster than 20S, 
with little 9S dimers or small aggregates present, as determined by SDG ultra- 
centrifugation. However, these large aggregates were ineffective as inhibitors of 
binding of immune complexes to macrophages. The large aggregates required 
725  #g to give 50% inhibition;  this is equivalent to the amount of monomeric 
RGG required to give a similar degree of inhibition. 
Effect  of Proteolytic Enyzmes on Macrophage Receptor for ~G.--These exper- 524  ADHERENCE  OF  SOLUBLE  COMPLEXES  TO  MACROPHAGES 
iments were carried out to study the sensitivity of the macrophage receptor for 
3'G to proteolytic enzymes. Portions of alveolar macrophages in Hanks' solution 
with Ca  ++ were preincubated with 10-100/~g/ml of trypsin, chymotrypsin, or 
pronase for 30 min at 37°C. The enzymes were then removed by four washings 
with Hanks' solution. The cells were resuspended in Medium 199, and the ad- 
herence of immune complexes was evaluated.  SDG ultracentrifugation of the 
complexes in the supernatants after the experiments showed no evidence of deg- 
radation of the complexes, indicating that the proteolytic enzymes were com- 
pletely  removed by earlier  washing.  The  extent  of  adherence  was compared 
with that seen with control cells handled similarly but not exposed to enzymes. 
TABLE II 
Effect of Proteolytic  Enzymes on Adherence  of Soluble Complexes to Macrophages 
Enzyme pretreatment  Per cent adherence* 
,~g/ml  % 
A. Trypsin  10  125 
50  142 
100  137 
B.  Chymotrypsin  10  101 
50  103 
100  113 
C.  Pronase  10  158 
50  146 
100  125 
* Represents results from two separate experiments. The actual amounts of complexes 
adherent ranged from 5 to 15% of the total available radioactivity. These amounts were 
compared with the amounts of complexes adherent to normal cells in control tubes. The 
control values were designated 100% adherence. 
An increase in immune complex binding over control levels  was seen  after 
pretreatment with each enzyme within the concentration range studied  (Table 
II). Pronase was the most potent in increasing the adherence and chymotrypsin 
the least effective. 
DISCUSSION 
The presented evidence confirms the observation that soluble immune com- 
plexes  possessing more than  two molecules of antibody in  their  lattice  work 
preferentially interact with  the  7G receptors on maerophages.  However,  the 
inhibition of adherence of soluble complexes by free "yG in the medium was not 
altered by the presence of complement, contrary to the inhibition of rosette for- 
mation of sensitized  erythrocytes around macrophages. Huber et al.  (2)  con- 
cluded that the macrophage receptors for 3'G and for C3 exerted a cooperative 
effect in  the binding of antibody-coated erythrocytes in  the  presence of free 
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cell sensitization,  in  that red cells sensitized with large amounts of antibody 
required more free ~G to cause comparable degrees of inhibition (18). However, 
recent studies failed to confirm the presence of a  distinct receptor for C3 on 
macrophages, and the suggestion was made that C3 potentiates phagocytosis, 
not adherence, through its peptidase activity (19). The experimental conditions 
in our studies were chosen to favor adherence, but not interiorization during 
the short preincubation of the inhibiting protein with the cells at room temper- 
ature. After the addition of the 2 #g of labeled antibodies in complexes, the in- 
cubation at 37°C for 30 rain should have been sufficient for the occurrence of 
full pinocytosis of the soluble complexes (20,  21). Although engulfment of the 
soluble complexes was not examined in these in vitro studies, our earlier in vivo 
studies showed that both adherence and degradation of soluble immune com- 
plexes by hepatic macrophages were not altered by complement depletion (4, 9). 
It can be concluded that both adherence of soluble complexes to macrophages 
and subsequent interiofization can occur in the absence of complement, even 
though  the soluble complexes are capable of fixing complement. In contrast, 
complement appears to play an important role in the interaction of sensitized 
erythrocytes with  macrophages. 
In our experiments, physiological amounts of 3'G in rabbit serum showed al- 
most complete inhibition of adherence of the soluble complexes to macrophages. 
However, the same complexes in vivo were rapidly taken up by the liver, with 
a serum disappearance half-life of 15 rain (4, 9). The reasons for these in vitro 
and in vivo differences have not been explained. It is possible that the macro- 
phages in suspension in our in vitro experiments were not so active in their sur- 
face receptor functions as the Kupffer cells in vivo. It is of interest that glass- 
adherent peripheral monocytes underwent biochemical and metabolic changes 
and exhibited an enhancement in phagocytosis of particles (22). Similarly, alve- 
olar macrophages exhibited 30 times the phagocytic capacity towards particles 
at 3-4 wk after culture on glass than at 1 day (23). The amount of complexes 
adherent to the macrophages in our studies was greatest when the donor ani- 
mals had received their last dose of CFA 2-3 wk previously. Other workers de- 
scribed a similar maximum in phagocytic activity of liver homogenates towards 
radiolabeled endotoxin suspensions 2 wk after intravenous injection  of  killed 
Calmette-Gu6rin bacillus  (24). However, it has not been shown  whether  this 
enhanced macrophage function is secondary to an increase in the numbers of 
macrophage receptors, or to a greater capacity of avidity of preexisting receptor 
sites.  Thus, it is possible that a  difference in macrophage receptor number or 
activity exists between the alveolar cells in our in vitro studies and the in vivo 
hepatic macrophages (4). 
The amount of inhibiting protein required to give 50 % inhibition of adher- 
ence of soluble complexes served as an index of the relative strength of binding 
of the protein to macrophages: These studies indicated that the soluble com- 
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"yG,  even  though  the  latter  had  sedimentation  coefficients  similar  to  the 
complexes. We have shown that the llS HSA-anti-HSA complexes contain two 
molecules of antibody,  2 and others have demonstrated that the 9-10S 3'G ag- 
gregates are dimers  (25). Therefore, it appears reasonable to assume that the 
> llS complexes and > 9S aggregates contain a comparable number of 3'G mol- 
ecules. Not only did the immune complexes exhibit greater adherence to macro- 
phages, they also were more efficient in complement fixation than were the small 
aggregates. These  observations suggested that soluble immune complexes pos- 
sessed structural characteristics not present in the small aggregates of 3'G, and 
that these characteristics contributed to the enhanced observed biological ac- 
tivities. Conformational changes in the antibodies in soluble immune complexes 
or a particular arrangement of the 3~G molecules in the lattice work of the solu- 
ble complexes may account for these differences. 
Our studies demonstrated that reduction and alkylation of the antibodies in 
the complexes decreased their strength of binding to macrophages, both in direct 
adherence and in inhibition of binding of complexes with intact antibodies. Sim- 
ilarly, reduction and alkylation decreased the inhibiting capacity of aggregated 
or monomeric RGG preparations. Previous investigators have shown that the 
cytophilic properties of guinea pig 3'1  antibodies were decreased by reduction 
and alkylation (20). Also, recent studies from our laboratory have shown that 
reduction and alkylation of 3"G antibodies markedly decreased the in vivo up- 
take of soluble complexes by fixed tissue macrophages of the liver (4). It is of 
interest that complexes prepared with reduced and  alkylated antibodies were 
more strongly adherent to macrophages than was intact aggregated RGG. This 
observation  suggested  that  the  immune  complexes still  possessed  structural 
characteristics which are important for binding to macrophages, even after rup- 
ture of the interchain disulfide bonds of the constituent  antibody molecules. 
Furthermore, reduction  and  alkylation of antibodies decreased the  ability of 
immune complexes to fix complement to a greater degree than it did their ability 
to adhere to macrophages (see Table I). 
Other workers have concluded that similar molecular interactions occur upon 
formation of soluble complexes and  aggregates of 3'G. The majority of heat- 
aggregated HGG has been shown to be linked through Fab fragments, by disul- 
fide bonds  and  noncovalent interactions  (8).  In  immune  complexes the  Fab 
regions of the antibodies are approximated by noncovalent bonds with the anti- 
gen. It is not known whether RGG is aggregated in a manner similar to HGG. 
Comparable changes in optical rotation have been observed in soluble irnmune 
complexes (26), in dimers of HGG (27), and in heat-aggregated HGG (28); this 
implies the presence of similar conformational changes in  the 3'G molecule in 
both complexes and "yG aggregates. In addition, inmmnological techniques have 
detected identical antigenic changes in the Fc fragments of the HGG antibodies 
in  soluble complexes and  in HGG aggregated by a  variety of methods  (29). 
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antibody there are differences in the susceptibility of the Fab fragment to deg- 
radation by proteolytic enzymes, which suggests that the molecular interactions 
are not entirely similar (8, 30). 
Electron microscopy has revealed conformational changes in the 3'G molecule 
upon  combination  with  antigen,  although  there  are  few  data  linking  these 
changes to biological activities of the molecule (31). The combination of small 
haptens with antibodies induced minimal conformational alterations in the anti- 
body as detected either by electron microscopy (31, 32) or by circular dichroism 
(33).  On  the  other hand,  large  protein  antigens  appeared  to induce greater 
changes in the corformation of antibodies than did small antigens, as detected 
by both electron microscopy (34) and optical techniques (28). These observa- 
tions might explain some of the differences between the results reported here 
and the studies of Phillips-Quagliata et al.  (7). These authors utilized a system 
of haptens of varying valency and  antibodies prepared against a multivalent 
hapten. They noted greatest adherence of soluble complexes when prepared in 
antibody excess with polyvalent hapten, and they concluded that the binding 
of soluble complexes to macrophages was due to a summation of individual bind- 
ing sites rather  than to conformational changes in antibody molecules. How- 
ever, because of their small size the haptens used as antigens may not have in- 
duced a significant conformational change. The observation that only 50 #g of 
free 3'G gave 50% inhibition of their complexes,  as opposed to the 710/~g in 
our studies, may be partially explained by differences in experimental condi- 
tions, but is also implies that the HSA-anti-HSA complexes prepared in antigen 
excess in our studies adhered more strongly. 
Our studies offer no direct evidence for the possible effect of conformational 
changes in the antibodies on increasing the biological activities of the soluble 
complexes. However, the recently published studies of Thrasher and Cohen (35) 
suggest that this change may be important. These authors contended that the 
greater  sensitivity  of  the  indirect  cytophilic  assay  (sensitized  erythrocytes 
added to macrophages),  as opposed to the direct cytophilic assay (cytophilic 
antibody reacted  with  macrophages,  unsensitized  erythrocytes added  later) 
(20), is not explained solely by a summation of individual binding sites. Further- 
more, their studies suggested that the receptor sites for cytophilic antibody on 
macrophages  were  too widely spaced  to offer the  grouping of  3'G  molecules 
necessary for complement fixation. This observation suggests that summation 
effects may not be so important as the increased binding offered by the individ- 
ual antibody after reaction with the antigenic determinant on the erythrocyte. 
An alternative explanation for the preferential binding of soluble complexes 
to macrophages might be a specificity offered by the lattice work. The 3'G anti- 
bodies in the lattice of soluble complexes might be oriented in a manner that 
leads to interaction and a potentiation of binding. It is possible that the arrange- 
ment of Fc fragments in the soluble complexes closely approximates the distri- 
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number of receptors for 3'G on alveolar macrophages has been estimated to be 
around 2 million per cell (7), their distribution is not known. This site density 
might be important in explaining some of the above observations. The failure 
of the large heat aggregates of vG to inhibit the binding of soluble complexes 
could be due to the smaller number of molecular aggregates per unit weight of 
3'G, in that there would thus be enough receptors left free to interact with the 
complexes. In the small aggregates of 3'G the orientation of molecules may be 
different than in the immune complexes, a difference which could result in ineffi- 
cient interaction of these aggregates with receptor sites. Similarly, in the studies 
of Phillips-Quagliata et al.  (7), the lattice work in the complexes made in  anti- 
body excess might be different from that in our complexes made in antigen ex- 
cess using a large multivalent antigen. 
Pretreatment of macrophages with  proteolytic enzymes increased  the  ad- 
herence of soluble complexes. Most studies have concluded that the macrophage 
receptor for ~,G, as opposed to the receptor for C3, is not trypsin sensitive. An 
enhanced binding of sensitized red cells,  i.e.  increased amounts, after pretreat- 
ment of the macrophages with proteolytic enzymes was recently described by 
LoBuglio and  Rinehart  (36); the results were similar  to  those of our studies 
using soluble immune complexes. These studies suggest that enzyme treatment 
may remove inhibiting material adjacent to the receptors for 3'G on the macro- 
phages. They do not indicate whether more sites are exposed or the preexisting 
sites exhibit an enhanced binding capacity. 
SUMMARY 
The adherence of soluble immune complexes to sthnulated  alveolar macro- 
phages was studied in vitro using HSA-anti-HSA complexes prepared in antigen 
excess. Those complexes containing more than two molecules of antibody pref- 
erentially adhered to macrophages in the absence of complement. Free "yG in 
less  than  physiological concentrations inhibited  the  adherence of  complexes, 
and the presence of complement did not significantly alter this inhibition. Com- 
plexes prepared with reduced and alkylated antibodies showed a decreased ad- 
herence. The strength of binding of soluble complexes to macrophages and their 
efficiency in fixing complement were greater than seen with small aggregates of 
homologous "yG. These differences in biological properties were observed even 
though the immune complexes and aggregates contained comparable numbers of 
7G molecules. The "~G receptor on rabbit macrophages exhibited species speci- 
ficity. Pretreatment of macrophages with proteolytic enzymes led to adherence 
of larger amounts of soluble complexes. 
These observations suggest that the strength of binding of soluble immune 
complexes to macrophages and their efficiency in fixing complement are not de- 
termined solely by a random summation of individual binding sites. It is pro- 
posed that conformational changes in the "yG antibodies or a specific molecular WILLIAM  P.  AREND  AND  MART  MANNIK  529 
arrangement in the lattice work of complexes containing large protein antigens 
may influence the biological properties  of the soluble complexes. 
It is a pleasure to acknowledge the excellent technical assistance of Mr. Douglas Webster. 
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